Phase 3 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed (confirmed by tissue or cell testing) with squamous cell carcinoma (a type of cancer) in the mouth area — this includes the tongue, floor of the mouth, inner lip, inner cheek, lower or upper gum ridge, the area behind the back molars, or the roof of the mouth
- People whose cancer is at an early stage (T1 or T2, with no spread to lymph nodes or distant parts of the body, based on standard staging guidelines), confirmed by a physical examination and head/neck and chest imaging done within the past 42 days
- People who a surgeon has assessed as suitable for a specific type of surgery involving removal of the main tumour through the mouth and a lymph node procedure in the neck, all done within the past 42 days
- People aged 18 or older
- People with a general health and activity level that falls within an acceptable range (confirmed by assessment within the past 42 days)
- Women who could become pregnant must have had a negative pregnancy test (blood or urine) within the past 42 days
- People who are able to read and understand English or French (required because a key questionnaire used in this trial is only available in those two languages)
- People who have completed a specific quality-of-life questionnaire (called the NDII) before moving to the next stage of the trial
- People whose PET/CT scan (a type of imaging scan done before the second stage of the trial) shows no cancer in the lymph nodes, as confirmed by a central review team
- People (or their legal representative) who have given written consent to participate in the study
Who may not be able to join:
- People whose cancer has already clearly spread to lymph nodes in the neck or to other parts of the body
- People who have had another type of invasive cancer (not counting certain treated skin cancers or early-stage breast or cervical conditions) unless they have been cancer-free for at least 2 years
- People whose squamous cell carcinoma is located in other parts of the throat or voice box area (such as the oropharynx, nasopharynx, hypopharynx, or larynx) rather than the mouth
- People who are unwilling or unable to complete the required questionnaire
- People who have previously received chemotherapy specifically for this mouth cancer (prior chemotherapy for a different cancer may be acceptable — confirm with trial site)
- People who have had radiation therapy to the same area of the body in a way that would overlap with any future radiation treatment
- People with serious ongoing health conditions that would make neck surgery too risky
- People who are pregnant or breastfeeding
- People whose mouth cancer was not fully removed, leaving a positive (cancerous) margin after surgery — though a prior biopsy-style removal is acceptable
- People who have had prior surgery to the side of the neck (such as a previous neck dissection or a serious neck injury that would prevent further surgery in that area) — prior thyroid surgery or a simple biopsy may be acceptable (confirm with trial site)
- People with a known history of blood cancers (such as certain types of leukaemia) or other active conditions known to cause enlarged lymph nodes (such as sarcoidosis or untreated tuberculosis-type infections)
- People currently receiving chemotherapy, immunosuppressive medicines, or other treatments that affect the immune system
- People currently taking part in another clinical trial involving an experimental treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient-reported neck and shoulder function (Phase II/III); Patient reported quality of life (QOL) (Phase II); Disease-free survival (DFS) (phase III)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.